Consensus Recommendations for MRD Testing in Adult B-Cell Acute Lymphoblastic Leukemia in Ontario

Consensus Recommendations for MRD Testing in Adult B-Cell Acute Lymphoblastic Leukemia in Ontario

Measurable (minimal) residual disease (MRD) is an established, key prognostic factor in adult B-cell acute lymphoblastic leukemia (B-ALL), and testing for MRD is known to be an important tool to help guide treatment decisions. The clinical value of MRD testing depends on the accuracy and reliability...

Full description

Bibliographic Details
Main Authors: Anne Tierens, Tracy L. Stockley, Clinton Campbell, Jill Fulcher, Brian Leber, Elizabeth McCready, Peter J. B. Sabatini, Bekim Sadikovic, Andre C. Schuh
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Current Oncology
Subjects:
adult B-cell acute lymphoblastic leukemia
adult acute lymphoblastic leukemia
flow cytometry
minimal residual disease
measurable residual disease
next-generation sequencing
Online Access:https://www.mdpi.com/1718-7729/28/2/131

Internet

https://www.mdpi.com/1718-7729/28/2/131

Similar Items